Deverra Therapeutics, Inc. is a company headquartered in the United States.
Deverra Therapeutics is a clinical-stage biotechnology company developing allogeneic, off-the-shelf universal donor cellular immunotherapies using umbilical cord blood–derived cells for treatment of cancer and infectious diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.